ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Immunogenicity"

  • 2017 American Transplant Congress

    In Vitro Optimisation of the Immunotherapeutic Effects of Umbilical Cord Derived MSC.

    S. de Witte,1 A. Merino,1 M. Franquesa,1 T. Strini,1 J. van Zoggel,1 S. Korevaar,1 F. Luk,1 M. Gargesha,4 D. Roy,4 S. Elliman,2 P. Newsome,3 C. Baan,1 M. Hoogduijn.1

    1Department of Internal Medicine, ErasmusMC, Rotterdam, Netherlands; 2Orbsen Therapeutics Ltd., Galway, Ireland; 3Department of NIHR Liver Biomedical Research Unit and Centre for Liver Research, University of Birmingham, Birmingham, United Kingdom; 4BioInVision Inc., Mayfield Village

    Mesenchymal stromal cells (MSC) possess immunomodulatory properties and are low immunogenic, which are both important for their development into an effective cellular immunotherapy after organ…
  • 2017 American Transplant Congress

    Soluble Human Leukocyte Antigen-G Levels and Prolonged Allograft Survival: A Demographic Analysis.

    C. Callaway,1 A. Ajith,2 V. Portik-Dobos,2 P. Best,3 C. Zayas,3 R. Kapoor,3 A. Horuzsko,2 L. Mulloy.3

    1Medical College of Georgia, Augusta University, Augusta, GA; 2Georgia Cancer Center, Augusta University, Augusta, GA; 3Section of Nephrology, Department of Medicine, Augusta University, Augusta, GA

    Human leukocyte antigen-G (HLA-G) is a tolerogenic protein shown to contribute to allograft survival. Dimerized, soluble HLA-G (sHLA-Gd) has been shown to significantly prolong allograft…
  • 2017 American Transplant Congress

    Circulating Inflammatory Factors in Deceased Organ Donors Result in Innate Immune Activation.

    T. Brennan, L. Lin, J. Pollara.

    Surgery, Duke University, Durham, NC

    Background: Superior outcomes of living-donor compared to deceased-donor transplants may be related to increased graft immunogenicity at the time of transplant. Donor brain death results…
  • 2016 American Transplant Congress

    Immunogenic HLA-DR Eplet Mismatches as Predictors of Transplant Glomerulopathy.

    D. Blum,1 K. Tinckam,2 M. Marrari,3 J. Kim,2 R. Sapir-Pichhadze.1

    1McGill University, Montreal, Canada; 2University Health Network, Toronto, Canada; 3University of Pittsburgh Medical Center, Pittsburgh.

    BackgroundThe number of HLA-DR eplet mismatches (eplet load) is a risk factor for the development of anti-HLA antibodies and transplant glomerulopathy (TG). In the case…
  • 2016 American Transplant Congress

    High Concentrations of CXCL9 and CXCL10 Chemokines but Not CXCL8 (IL-8), IL-6, TNF-a or IFN-g in Biopsy Tissue Are Associated with Pathological Staging of Rejection After Kidney Transplantation.

    C. Falk,1 C. Neudörfl,1 K. Daemen,1 J. Keil,1 F. Lehner,2 H. Haller,3 J. Schmitz,4 C. Blume,5 J.-H. Bräsen.4

    1Institute of Transplant Immunology, IFB-Tx, Hannover Medical School, Hannover, Germany; 2Department of Abdominal and Transplantation Surgery, Hannover Medical School, Hannover, Deutschland, Germany; 3Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Deutschland, Germany; 4Institute of Pathology, Hannover Medical School, Hannover, Deutschland, Germany; 5Institute of Technical Chemistry, Leibniz University Hannover, Hannover, Deutschland, Germany.

    Background: Extensive expression profiling efforts of biopsy tissue after kidney transplantation indicate that rejection, especially antibody-mediated rejection (AMR) can be defined by distinct signatures. Thus,…
  • 2016 American Transplant Congress

    A Novel Humanized Mouse Model Incorporating Non-Fetal Tissue.

    M. Brown, I. Norman, Y. Zhou, W. Lou, J. Sullivan, W. Burlingham.

    Surgery/Transplant Division, University of Wisconsin-Madison, Madison, WI.

    Pre-clinical research into allogeneic tissue transplantation therapies, as well as patient-specific regenerative medicine studies, require animal models that closely mimic the typical patient's immune response.…
  • 2016 American Transplant Congress

    Activation of Innate Immunity During Human OLT-IRI Triggers Adaptive Immunity and Correlates with the Degree of IRI Injury.

    A. Zarrinpar,1 R. Sosa,2 P. Rao,2 C. Lassman,2 R. Busuttil,1 D. Gjertson,2 J. Kupiec-Weglinski,1 E. Reed.2

    1Surgery, Dumont-UCLA Transplant Ctr, Los Angeles, CA; 2Pathology, UCLA, Los Angeles, CA.

    Ischemia reperfusion injury (IRI) in orthotopic liver transplantation (OLT) can severely compromise graft and recipient survival. We postulate this is mediated by interactions between the…
  • 2016 American Transplant Congress

    Optimizing the Immunogenicity and Immunomodulatory Properties of MSC for Cellular Therapy.

    S. de Witte,1 M. Franquesa,1 T. Strini,1 S. Korevaar,1 F. Luk,1 S. Elliman,2 P. Newsome,3 M. Gargesha,4 D. Roy,4 A. Merino,1 C. Baan,1 M. Hoogduijn.1

    1ErasmusMC, Rotterdam, Netherlands; 2Orbsen Therapeutics, Galway, Ireland; 3University of Birmingham, Birmingham, United Kingdom; 4Bioinvision, Mayfield Village.

    Mesenchymal stromal cells (MSC) are candidates for immunotherapy after transplantation. MSC have shown to be immunomodulatory and low immunogenic, which is favorable for cellular therapy…
  • 2016 American Transplant Congress

    Dendritic Cells and Damage-Associated Molecular Patterns in Aging.

    M. Seyda, H. Li, G. Liu, M. Quante, H. Uehara, J. Schuitenmaker, A. Elkhal, S. Tullius.

    Division of Transplant Surgery and Transplant Surgery Research Laboratory, Brigham and Women's Hospital, Boston.

    Recently, it has been shown that Dendritic Cells (DCs) of old organs accelerate graft rejection by orchestrating IL-17A-mediated T cell responses. Moreover, cell-free DNA has…
  • 2016 American Transplant Congress

    Biopsy-Proven Rejection in Children After Liver Transplantation Is Associated by an IL-12p40-Mediated Innate Immune Response Followed by Th1 T Cell Activation.

    C. Falk,1 I. Goldschmidt,2 F. Mutschler,2 E. Pfister,2 F. Lehner,3 J. Keil,1 C. Neudörfl,1 A. Karch,4 R. Mikolajczyk,4 U. Baumann.2

    1Institute of Transplant Immunology, IFB-Tx, Hannover Medical School, Hannover, Bitte Wählen, Germany; 2Department of Pediatric Hepatology, Hannover Medical School, Hannover, Bitte Wählen, Germany; 3Department of Abdominal and Transplantation Surgery, Hannover Medical School, Hannover, Bitte Wählen, Germany; 4Department of Epidemiology, Helmholtz Center for Infection Research, HZI, Braunschweig, Germany.

    Sustained by adaptive immune cells and their soluble mediators is well established for infection but it has not been demonstrated for solid organ transplantation in…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences